耐铵型产琥珀酸放线杆菌的选育

以Actinobacillus succinogenes NJ113为出发菌株,经硫酸二乙酯(DES)诱变,在含8～20 g/L硫酸铵平板中筛选到一株耐铵型突变株YZ25,该菌株在含8 g/L硫酸铵培养基中厌氧发酵,琥珀酸产量达32.68 g/L,比出发菌提高了180.5%,对葡萄糖收率达65.4%,副产物乙酸、甲酸产量分别下降3.5%、28.7%,琥珀酸/乙酸比值由0.63提高到2.5。在7.5 L发酵罐中,用氨水调节pH分批实验,发酵34 h琥珀酸产量达27.13 g/L,较出发菌株提高了85.3%。     

重组猪胸膜肺炎放线杆菌毒素ApxI对小鼠的急性毒性和免疫保护性研究

研究了猪胸膜肺炎放线杆菌毒素Ⅰ重组表达蛋白(包括粗提包涵体和经复性处理的重组蛋白)对小鼠的急性毒性以及免疫保护性,并和天然毒素Ⅰ(由APP血清10型菌的培养物上清提取)做了对比。在急性毒性试验中,3种蛋白均以200μg只的剂量腹腔注射小鼠,并分别于24h、7d和14d后眼眶放血致死,检测血常规和血液生化相关指标。结果表明,3种蛋白均不引起小鼠死亡,且重组表达蛋白对小鼠的生长、血常规和血液生化指标没有显著影响。在免疫保护性试验中,用3种蛋白乳化后免疫小鼠,2周后加强免疫1次,并在每次免疫后采血检测其效价,二免2周后用致死剂量的APP血清10型菌(1.09×108cfu)腹腔攻毒。结果表明,天然毒素和复性的重组表达蛋白均具有良好的免疫原性,对小鼠具有较好的免疫保护效力。     

Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria

Actinobacillus pleuropneumoniae is the causative agent of porcine pleuropneumonia. Among the virulence factors, ApxIIA, a bacterial exotoxin, is reportedly expressed in many serotypes and is considered as a candidate for the development of a vaccine against the bacterial infection. Previously, we isolated a field strain of A. pleuropneumoniae serotype 2 in Korea and characterized its exotoxins to develop an oral vaccine. In this study, we initially confirmed the immunogenicity of ApxIIA expressed in Escherichia coli. We then developed transgenic tobacco expressing ApxIIA and tested its efficacy to induce a protective immune response against A. pleuropneumoniae infection after oral administration of the plant powder. We observed that protective immune responses were induced in mice after oral administration of the plant powder once a week for 4 weeks. Immunoassays revealed that the levels of antigen-specific immunoglobulin G against ApxIIA increased in mice that were fed a powder made from the transgenic plant, but not in mice fed a powder made from wild-type tobacco. Additionally, mice fed the transgenic plant powder were protected from an injection of a lethal dose of A. pleuropneumoniae. These results support that the transgenic plant may be a suitable candidate for an oral vaccine that could be used effectively against A. pleuropneumoniae infection.     

A single-step transconjugation system for the introduction of unmarked deletions into Actinobacillus pleuropneumoniae serotype 7 using a sucrose sensitivity marker

Research on the porcine respiratory tract pathogen Actinobacillus pleuropneumoniae requires the availability of improved genetic tools. Therefore, using the sacB gene of Bacillus subtilis, we developed a sucrose-based counterselection system that allows rapid curing of an Escherichia coli-A. pleuropneumoniae shuttle vector as well as the introduction of unmarked mutations into the A. pleuropneumoniae chromosome. A cassette containing the Tn903 kanamycin resistance determinant (km(r)) and the sacB gene expressed from the A. pleuropneumoniae omlA promoter was introduced by homologous recombination into the ureC gene of A. pleuropneumoniae. The resultant stable plasmid cointegrates were kanamycin-resistant, sucrose-sensitive, and urease-positive. A simple counterselection on sucrose-containing agar plates without an additional transconjugation step allowed the efficient isolation of urease-negative A. pleuropneumoniae mutants that had lost the km(r)-sacB cassette.     

Cloning, sequence analysis and heterologous expression of the DNA adenine-(N(6)) methyltransferase from the human pathogen Actinobacillus actinomycetemcomitans

We cloned and sequenced the DNA adenine-N(6) methyltransferase gene of the human pathogen Actinobacillus actinomycetemcomitans (M.AacDAM). Restriction digestion shows that the enzyme methylates adenine in the sequence GATC. Expression of the enzyme in a DAM(-) background shows in vivo activity. A PSI-BLAST search revealed that M.AacDAM is most related to M.HindIV, M.EcoDAM, M.StyDAM, and M.SmaII. The ClustalW alignment shows highly conserved regions in the enzyme characteristic for type a MTases. Phylogenetic tree analysis shows a cluster of enzymes recognizing the sequence GATC, within a branch of orphan MTases harboring M.AacDAM. The cloning and sequencing of this first methyltransferase gene described for A. actinomycetemcomitans open the path for studies on the potential regulatory impact of DNA methylation on gene regulation and virulence in this organism.     

超高静压在琥珀酸生产菌株选育中的应用

采用超高静压对一株产琥珀酸放线杆菌A3进行诱变育种, 进一步提高其生产性能。考察了压力、变压速度、生长期对菌株致死率的影响。在压力为200 MPa, 50 MPa/min变压速度的诱变条件下对稳定期菌株进行诱变, 筛选到一株突变菌株产琥珀酸放线杆菌B19, 琥珀酸产量达到 32.2 g/L, 比出发菌株A3提高了17.9%, 代谢副产物乙酸的产量降低了11.5%, 经过6次传代表明突变菌株具有稳定的遗传特性。     

Actinomycetemcomitin: a new bacteriocin produced by <Emphasis Type="Italic">Aggregatibacter</Emphasis> (<Emphasis Type="Italic">Actinobacillus</Emphasis>) <Emphasis Type="Italic">actinomycetemcomitans</Emphasis>

Aggregatibacter (Actinobacillus) actinomycetemcomitans P_7–20 strain isolated from a periodontally diseased patient has produced a bacteriocin (named as actinomycetemcomitin) that is active against Peptostreptococcus anaerobius ATCC 27337. Actinomycetemcomitin was produced during exponential and stationary growth phases, and its amount decreased until it disappeared during the decline growth phase. It was purified by ammonium sulphate precipitation (30–60% saturation), and further by FPLC (mono-Q ionic exchange and Phenyl Superose hydrophobic interaction) and HPLC (C-18 reversed-phase). This bacteriocin loses its activity after incubation at a pH below 7.0 or above 8.0, following heating for 30 min at 45°C, and after treatment with proteolytic enzymes such as trypsin, α-chymotrypsin, and papain. Actinomycetemcomitin has a molecular mass of 20.3 KDa and it represents a new bacteriocin from A. actinomycetemcomitans.     

胸膜肺炎放线杆菌基因分型方法的建立及其临床应用

根据胸膜肺炎放线杆菌各血清型之间外毒素(Apx),外膜脂蛋白(OmlA),转铁蛋白B(TbpB)的基因差异,分别对各血清型进行PCR扩增,得到不同的特异性片段,可区分开生物Ⅰ型13个标准菌株血清型中的8个血清型。临床检测结果与血清学分型一致,将此分型系统用于临床送检的126份肺脏和42份扁桃体的病原学检测,可直接检测出胸膜肺炎放线杆菌感染。此方法还可以将一些尚未定型的菌株进行归类,弥补了血清学方法的不足,为细菌的流行病学调查提供了可靠的技术手段。